Skip to main content
Michael Rubin, MD, Neurology, Dallas, TX, University of Texas Southwestern Medical Center

MichaelARubinMDMA

Neurology Dallas, TX

Neurocritical Care

Associate Professor, Neurology and Neurosurgery, UT Southwestern School of Medicine

Dr. Rubin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rubin's full profile

Already have an account?

Summary

  • Academic Neurointensivist and Clinical Ethicist

Education & Training

  • Loyola University Chicago
    Loyola University ChicagoMA, Bioethics and Health Policy, 2013
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Neurology, 2005 - 2008
  • John Peter Smith Hospital (Tarrant County Hospital District)
    John Peter Smith Hospital (Tarrant County Hospital District)Internship, Transitional Year, 2004 - 2005
  • Texas Tech University Health Sciences Center School of Medicine
    Texas Tech University Health Sciences Center School of MedicineClass of 2004
  • University of Texas at Austin: College of Liberal Arts
    University of Texas at Austin: College of Liberal ArtsBA, Plan II Honors Liberal Arts Program, 1998

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2013 - 2024
  • MO State Medical License
    MO State Medical License 2008 - 2014
  • American Board of Psychiatry and Neurology Neurology
  • UCNSNeurocritical Care

Awards, Honors, & Recognition

  • Presidential Service Award Neurocritical Care Society, 2015
  • Presidential Citation Neurocritical Care Society, 2015

Publications & Presentations

PubMed

Books/Book Chapters

Lectures

  • Racial Disparity at End of Life and the ICU 
    Texas State University; Department of Philosophy San Marcos, TX - 1/26/2015
  • UT Southwestern Neurotherapeutics Update 
    Medical Futility and Potentially Inappropriate Therapy - 1/14/2015
  • Aggressive Management of Catastrophic Brain Injury 
    1/13/2015
  • Join now to see all

Press Mentions

  • Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira Immunologics
    Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira ImmunologicsAugust 27th, 2020

Professional Memberships

Hospital Affiliations